Guy Young
Director, Hemostasis and Thrombosis Program · Children's Hospital Los Angeles
Credentials: · · · · ·
History
PresentHemostasis and Thrombosis Program · Children's Hospital Los Angeles
- 1995–1996
Pediatric Hematology-Oncology
- 1992–1995
Pediatrics
Research
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
New England Journal of Medicine · 2017 · 891 citations
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
New England Journal of Medicine · 2016 · 392 citations
The past and future of haemophilia: diagnosis, treatments, and its complications
Review · The Lancet · 2016 · Last of 3 authors · 387 citations
21 papers
20 papers
17 papers · 1 as a fellow
- NG
17 papers · 2 as a fellow
- RS
12 papers
11 papers
10 papers
10 papers · 3 as a resident
Grants
- 2008–2013
Dose-Finding, Pharmacokinetic, Safety and Efficacy of Bivalirudin in Children
National Heart, Lung, and Blood Institute · R01
Contact PI · $386.6K · Children's Hospital of Los Angeles
- 2006–2009
Fondaparinum in Children with Thrombosis
Food and Drug Administration · R01
Contact PI · $440.5K · Children's Hospital of Los Angeles
Clinical trials
- 2020–2025
Preventing Inhibitor Recurrence Indefinitely
Principal investigator · Unknown · Phase 4
Children's Hospital Los Angeles
- 2020–2022
Principal investigator · Active not recruiting · Phase 4
Children's Hospital Los Angeles
- 2017–2019
Individualizing Hemophilia Bypassing Agent Therapy Utilizing Thromboelastography
Principal investigator · Withdrawn
Children's Hospital Los Angeles
- 2008–2013
The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids
Principal investigator · Completed · Phase 1
Children's Hospital Los Angeles